ORIC - ORIC Pharmaceuticals Inc
12.59
0.940 7.466%
Share volume: 1,799,812
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$11.65
0.94
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-06-2024 | 08-12-2024 | 11-12-2024 | 02-18-2025 | 05-05-2025 | 11-13-2025 | 02-23-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 28.990 M | 36.017 M | 38.318 M | 39.570 M | 32.718 M | 36.671 M | 34.551 M | |
| Selling general and admin | 7.030 M | 7.077 M | 7.116 M | 7.600 M | 8.078 M | 7.898 M | 8.695 M | |
| Research and development | 21.960 M | 28.940 M | 31.202 M | 31.970 M | 24.640 M | 28.773 M | 25.856 M | |
| Total expenses | 28.990 M | 36.017 M | 38.318 M | 39.570 M | 32.718 M | 36.671 M | 34.551 M | |
| 24.24% | 6.39% | 3.27% | -17.32% | 12.08% | -5.78% | |||
| Operating income | -28.990 M | -36.017 M | -38.318 M | -39.570 M | -32.718 M | -36.671 M | -34.551 M | |
| Ebit | -28.990 M | -36.017 M | -38.318 M | -39.570 M | -32.718 M | -36.671 M | -34.551 M | |
| Pretax income | -25.011 M | -31.963 M | -34.566 M | -36.307 M | -30.021 M | -32.587 M | -30.505 M | |
| 27.80% | 8.14% | 5.04% | -17.31% | 8.55% | -6.39% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -25.011 M | -31.963 M | -34.566 M | -36.307 M | -30.021 M | -32.587 M | -30.505 M | |
| -27.80% | -8.14% | -5.04% | 17.31% | -8.55% | 6.39% |